136 related articles for article (PubMed ID: 20396980)
1. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
Zhang YH; Zhang H; Liu JM; Yue ZJ
Med Oncol; 2011 Sep; 28(3):901-6. PubMed ID: 20396980
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Zhang YH; Yue ZJ; Zhang H; Tang GS; Wang Y; Liu JM
Eur J Pharm Biopharm; 2010 Nov; 76(3):371-5. PubMed ID: 20816959
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.
Zhang H; Gao S
Int J Pharm; 2007 Feb; 329(1-2):122-8. PubMed ID: 17000068
[TBL] [Abstract][Full Text] [Related]
4. The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior.
Zhang D; Tian A; Xue X; Wang M; Qiu B; Wu A
Int J Mol Sci; 2012; 13(1):1109-1125. PubMed ID: 22312307
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of surgical tumor resection with implantation of a hydrogel containing camptothecin-loaded poly(lactic-co-glycolic acid) microspheres in a C6 rat glioma model.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Biol Pharm Bull; 2012; 35(4):545-50. PubMed ID: 22466559
[TBL] [Abstract][Full Text] [Related]
6. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP
Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel.
Ozeki T; Hashizawa K; Kaneko D; Imai Y; Okada H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1142-7. PubMed ID: 20823591
[TBL] [Abstract][Full Text] [Related]
12. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
[TBL] [Abstract][Full Text] [Related]
13. Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
Tseng YY; Su CH; Yang ST; Huang YC; Lee WH; Wang YC; Liu SC; Liu SJ
Oncotarget; 2016 Sep; 7(37):59902-59916. PubMed ID: 27494894
[TBL] [Abstract][Full Text] [Related]
14. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
15. Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy.
Ranganath SH; Kee I; Krantz WB; Chow PK; Wang CH
Pharm Res; 2009 Sep; 26(9):2101-14. PubMed ID: 19543956
[TBL] [Abstract][Full Text] [Related]
16. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
[TBL] [Abstract][Full Text] [Related]
19. [Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].
Li Y; Gao Y; Liu G; Zhou X; Wang Y; Wang Y; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):631-5. PubMed ID: 24849425
[TBL] [Abstract][Full Text] [Related]
20. Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.
Kang SG; Kim JS; Park K; Kim JS; Groves MD; Nam DH
Oncol Rep; 2006 Jan; 15(1):7-13. PubMed ID: 16328028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
